Ubs Oconnor LLC Atri Cure, Inc. Transaction History

Ubs Oconnor LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$32.99 - $43.25 $1.22 Million - $1.6 Million	-37,094 Reduced 75.25%	12,199 $435,000
Q3 2023 Nov 14, 2023	BUY	$41.12 - $57.73 $370,080 - $519,570	9,000 Added 22.34%	49,293 $2.16 Million
Q2 2023 Aug 14, 2023	BUY	$40.44 - $49.6 $1.63 Million - $2 Million	40,293 New	40,293 $1.99 Billion
Q1 2023 May 15, 2023	SELL	$35.87 - $47.22 $234,589 - $308,818	-6,540 Reduced 13.71%	41,160 $1.71 Million
Q4 2022 Feb 14, 2023	BUY	$33.48 - $47.45 $1.19 Million - $1.68 Million	35,400 Added 287.8%	47,700 $0
Q3 2022 Nov 14, 2022	BUY	$38.25 - $52.62 $470,475 - $647,226	12,300 New	12,300 $481 Million

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.43B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.